skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

Neuropsychiatric Disease and Treatment

(2,361,176) Views

Editor in Chief Dr Roger M Pinder

1176-6328


Effect of high-dose milnacipran in patients with depression
Masatoshi Hayashi, Masaru Mimura, Tempei Otsubo, Kunitoshi Kamijima
Neuropsychiatric Disease and Treatment 2007, 3:699-702
29 November 2007


Gabapentin-induced coma: A MR-spectrometry analysis
Lamine Abdennour, Paola Sanchez-Peña, Damien Galanaud, Vincent Navarro, Nicolas Weiss, et al
Neuropsychiatric Disease and Treatment 2007, 3:695-698
29 November 2007


Complex obsessive compulsive and impulsive symptoms in Tourette’s syndrome
Donna Palumbo, Roger Kurlan
Neuropsychiatric Disease and Treatment 2007, 3:687-693
29 November 2007


Increase of plasma brain-derived neurotrophic factor levels in two psychotic depressed patients responding to lithium addition to paroxetine treatment
Reiji Yoshimura, Koshiro Tsuji, Nobuhisa Ueda, Jun Nakamura
Neuropsychiatric Disease and Treatment 2007, 3:683-686
29 November 2007


Carisoprodol withdrawal induced delirium: A case study
Karen Ni, Margaret Cary, Paul Zarkowski
Neuropsychiatric Disease and Treatment 2007, 3:679-682
29 November 2007


Episodic vertigo resulting from vascular risk factors, cervical spondylosis and head rotation: Two case reports
Mayowa O Owolabi, Okechukwu S Ogah, Adesola Ogunniyi
Neuropsychiatric Disease and Treatment 2007, 3:675-678
29 November 2007


Structural integrity of the uncinate fasciculus in geriatric depression: Relationship with age of onset
Warren D Taylor, James R MacFall, Guido Gerig, Ranga R Krishnan
Neuropsychiatric Disease and Treatment 2007, 3:669-674
29 November 2007


Use of fMRI to predict psychiatric adverse effects of interferon treatment for Hepatitis C – preliminary report
Donald H Marks, Mehdi Adineh, Binquan Wang, Sudeepa Gupta
Neuropsychiatric Disease and Treatment 2007, 3:655-667
29 November 2007


Family history, early adversity and the hypothalamic-pituitary-adrenal (HPA) axis: Mediation of the vulnerability to mood disorders
Stuart Watson, Bruce M Owen, Peter Gallagher, Andrea J Hearn, Allan H Young, et al
Neuropsychiatric Disease and Treatment 2007, 3:647-653
29 November 2007


The clinical differentiation of fronto-temporal dementia from psychiatric disease
Peter K Panegyres, Angela Graves, Kate AR
Neuropsychiatric Disease and Treatment 2007, 3:637-645
29 November 2007


Potential cognitive enhancing and disease modification effects of SSRIs for Alzheimer’s disease
Tiffany W Chow, Bruce G Pollock, Norton W Milgram
Neuropsychiatric Disease and Treatment 2007, 3:627-636
29 November 2007


Dementia with Lewy bodies: Definition, diagnosis, and pathogenic relationship to Alzheimer’s disease
Robert E Mrak, W Sue T Griffin
Neuropsychiatric Disease and Treatment 2007, 3:619-625
29 November 2007


Whole genome association studies of neuropsychiatric disease: An emerging era of collaborative genetic discovery
Margaret A Keller, Katrina Gwinn, Josefina Nash, Jonathan Horsford, Ran Zhang, et al
Neuropsychiatric Disease and Treatment 2007, 3:613-618
29 November 2007


The amyloid beta ion channel hypothesis of Alzheimer’s disease
Najeeb A Shirwany, Daniel Payette, Jun Xie, Qing Guo
Neuropsychiatric Disease and Treatment 2007, 3:597-612
29 November 2007


Late-onset Diogenes syndrome in Chinese – an elderly case series in Hong Kong
Sau Man Sandra Chan, Pui Yiu Vivian Leung, Fung Kum Helen Chiu
Neuropsychiatric Disease and Treatment 2007, 3:589-596
28 November 2007


Review of olanzapine in the management of bipolar disorders
Meera Narasimhan, Travis O Bruce, Prakash Masand
Neuropsychiatric Disease and Treatment 2007, 3:579-587
28 November 2007


Progress update: Pharmacological treatment of Alzheimer’s disease
David B Hogan
Neuropsychiatric Disease and Treatment 2007, 3:569-578
28 November 2007


Sleep deprivation: Impact on cognitive performance
Paula Alhola, Päivi Polo-Kantola
Neuropsychiatric Disease and Treatment 2007, 3:553-567
28 November 2007


Tetrabenazine in the treatment of Huntington’s disease
Diana Paleacu
Neuropsychiatric Disease and Treatment 2007, 3:545-551
28 November 2007


Update on the management of neuromuscular block: focus on sugammadex
Hans D de Boer, Jan van Egmond, Jacques J Driessen, Leo HD Booij
Neuropsychiatric Disease and Treatment 2007, 3:539-544
28 November 2007


Transdermal selegiline for the treatment of major depressive disorder
Kelly C Lee, Jack J Chen
Neuropsychiatric Disease and Treatment 2007, 3:527-537
28 November 2007


Zolpidem modified-release in insomnia
Cynthia Kirkwood, Jason Neill, Ericka Breden
Neuropsychiatric Disease and Treatment 2007, 3:521-526
28 November 2007


Editorial Foreword: New antidepressants or more of the same? || FREE PAPER ||
Roger M Pinder
Neuropsychiatric Disease and Treatment 2007, 3:519-520
28 November 2007